The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats: Mephedrone increases both DA and 5-HT in rat brain
Open accessAbstract
BACKGROUND AND PURPOSE: The designer drug 1-(4-methylphenyl)-2-methylaminopropan-1-one (4-methylmethcathinone, mephedrone) is reported to possess psychostimulant, entactogenic and hallucinogenic effects. The purpose of this study was to examine the effects of acute administration of mephedrone on extracellular levels of dopamine (DA) and 5-HT in the nucleus accumbens of awake rats and compare these effects with those induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and amphetamine. EXPERIMENTAL APPROACH: Microdialysis sampling was performed while simultaneously recording locomotor activity in rats and the monoamines were determined by HPLC with electrochemical detection. KEY RESULTS: Mephedrone (3 mg·kg(-1) s.c.) and (+)-amphetamine (1 mg·kg(-1) s.c.) caused rapid increases in extracellular DA levels of 496% and 412%, respectively, whereas MDMA (3 mg·kg(-1) s.c.) showed only a moderate effect (235%). The corresponding 5-HT levels increased to 941% (mephedrone) and 911% (MDMA), but only to 165% following amphetamine. The calculated t(1/2) values for elimination rate of mephedrone, MDMA and amphetamine-induced increases in extracellular DA levels were 25, 303 and 51 min, the corresponding t(1/2) values for 5-HT were 26, 48 and 84 min, respectively. Locomotor activity was increased most by amphetamine, whereas both mephedrone and MDMA showed about three times lower and shorter-lasting effects. CONCLUSIONS AND IMPLICATIONS: The neurochemical and functional properties of mephedrone resemble those of MDMA, but it also shows an amphetamine-like effect in that it evokes a rapid release and elimination of DA in the brain reward system, a feature that may contribute to its potent reinforcing properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Guide to receptors and channels (GRAC), 5th edition
Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947
Development of a rational scale to assess the harm of drugs of potential misuse
Nutt, D., King, L. A., Saulsbury, W., & Blakemore, C. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60464-4 · Cited by 1,302 · cited 2×
“RESEARCH PAPERbph_1499 1949..1958”
BackgroundRothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V., Rice, K. C., Carroll, F. I., & Partilla, J. S. (2001) · Synapse · doi:10.1002/1098-2396(20010101)39:1<32::aid-syn5>3.0.co;2-3 · Cited by 938
Guide to Receptors and Channels (GRAC), 3rd edition
Alexander, S. P. H., Mathie, A., & Peters, J. A. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707746 · Cited by 510
Modern Techniques in Neuroscience Research
(1999) · Springer eBooks · doi:10.1007/978-3-642-58552-4 · Cited by 452
Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, pharmacological and clinical issues
Schifano, F., Albanese, A., Fergus, S., Stair, J. L., Deluca, P., Corazza, O., Davey, Z., Corkery, J., Siemann, H., Scherbaum, N., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2070-x · Cited by 315
α1b-Adrenergic Receptors Control Locomotor and Rewarding Effects of Psychostimulants and Opiates
Drouin, C., Darracq, L., Trovero, F., Blanc, G., Glowinski, J., Cotecchia, S., & Tassin, J.-P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02873.2002 · Cited by 296
Meyer, M. R., Wilhelm, J., Peters, F. T., & Maurer, H. H. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-3636-5 · Cited by 272
A web-based survey on mephedrone
Carhart-Harris, R. L., King, L. A., & Nutt, D. J. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.02.011 · Cited by 244
Dargan, P. I., Albert, S., & Wood, D. M. (2010) · QJM · doi:10.1093/qjmed/hcq134 · Cited by 242
Case series of individuals with analytically confirmed acute mephedrone toxicity
Wood, D. M., Davies, S., Greene, S. L., Button, J., Holt, D. W., Ramsey, J., & Dargan, P. I. (2010) · Clinical Toxicology · doi:10.3109/15563650.2010.531021 · Cited by 215
Instability of the ecstasy market and a new kid on the block: mephedrone
Brunt, T. M., Poortman, A., Niesink, R. J., & van den Brink, W. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110378370 · Cited by 215
James, D., Adams, R. D., Spears, R., Cooper, G., Lupton, D. J., Thompson, J. P., Thomas, S. H. L., & Service, O. B. O. T. N. P. I. (2011) · Emergency Medicine Journal · doi:10.1136/emj.2010.096636 · Cited by 214
Wood, D. M., Davies, S., Puchnarewicz, M., Button, J., Archer, R., Ovaska, H., Ramsey, J., Lee, T., Holt, D. W., & Dargan, P. I. (2010) · Journal of Medical Toxicology · doi:10.1007/s13181-010-0018-5 · Cited by 206
A case of extreme agitation and death after the use of mephedrone in The Netherlands
Lusthof, K. J., Oosting, R., Maes, A., Verschraagen, M., Dijkhuizen, A., & Sprong, A. G. A. (2011) · Forensic Science International · doi:10.1016/j.forsciint.2010.12.014 · Cited by 190
Regulation of the dopamine transporter: Aspects relevant to psychostimulant drugs of abuse
Schmitt, K. C., & Reith, M. E. A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05148.x · Cited by 180
Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone
Wood, D. M., Greene, S. L., & Dargan, P. I. (2011) · Emergency Medicine Journal · doi:10.1136/emj.2010.092288 · Cited by 169
The clinical toxicology of metamfetamine
Schep, L. J., Slaughter, R. J., & Beasley, D. M. G. (2010) · Clinical Toxicology · doi:10.3109/15563650.2010.516752 · Cited by 164
Millan, M. J., Brocco, M., Gobert, A., Joly, F., Bervoets, K., Rivet, J., Newman‐Tancredi, A., Audinot, V., & Maurel, S. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00858.x · Cited by 149
Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse
Bubar, M. J., & Cunningham, K. A. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00916-3 · Cited by 147
Gudelsky, G. A., & Yamamoto, B. K. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.10.003 · Cited by 140
Kankaanpää, A., Meririnne, E., Lillsunde, P. M., & Seppαlä, T. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00527-3 · Cited by 140
Rothman, R. B., & Baumann, M. H. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.064 · Cited by 136
Mephedrone: still available and twice the price
WINSTOCK, A. R., Mitcheson, L., & Marsden, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)62021-1 · Cited by 117
Baumann, M. H., Clark, R. D., Woolverton, W. L., Wee, S., Blough, B. E., & Rothman, R. B. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.176271 · Cited by 110
Fletcher, P. J., Rizos, Z., Noble, K., & Higgins, G. A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.025 · Cited by 109
Milesi‐Hallé, A., Hendrickson, H. I., Laurenzana, E. M., Gentry, W. B., & Owens, S. M. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.04.007 · Cited by 100
Effects of cathinone and amphetamine on the neurochemistry of dopamine in vivo
Pehek, E. A., Schechter, M., & Yamamoto, B. K. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90041-o · Cited by 87
O’Shea, E., Escobedo, I., Orío, L., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300673 · Cited by 87
Rivière, G. J., Byrnes, K. A., Gentry, W. B., & Owens, S. M. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35230-9 · Cited by 85
Headshop heartache: acute mephedrone ‘meow’ myocarditis
Nicholson, P. J., Quinn, M. J., & Dodd, J. D. (2010) · Heart · doi:10.1136/hrt.2010.209338 · Cited by 79
Baumann, M. H., Żółkowska, D., Kim, I., Scheidweiler, K. B., Rothman, R. B., & Huestis, M. A. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028506 · Cited by 74
Ciano, P. D., Gouty, A., Depoortero, R. Y., Egilmez, Y., Lane, J. D., Emmett‐Oglesby, M. W., LePiane, F. G., Phillips, A. G., & Blaha, C. D. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199506000-00002 · Cited by 72
Cadoni, C., & Chiara, G. D. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04795.x · Cited by 59
Self-administration of mixtures of fenfluramine and amphetamine by rhesus monkeys
Wee, S., & Woolverton, W. L. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.05.022 · Cited by 56
Auclair, A. L., Blanc, G., Glowinski, J., & Tassin, J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02714.x · Cited by 55
Dependence and psychosis with 4-methylmethcathinone (mephedrone) use
Bajaj, N., Mullen, D., & Wylie, S. (2010) · BMJ Case Reports · doi:10.1136/bcr.02.2010.2780 · Cited by 53
Neural and Cardiac Toxicities Associated With 3,4-Methylenedioxymethamphetamine (MDMA)
Baumann, M. H., & Rothman, R. B. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)88010-0 · Cited by 51
Kurling, S., Kankaanpää, A., & Seppαlä, T. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.12.021 · Cited by 47
Monitoring Chemistry of Brain Microenvironment: Biosensors, Microdialysis and Related Techniques
Kehr, J. (1999) · Springer eBooks · doi:10.1007/978-3-642-58552-4_41 · Cited by 36
Self-citationHutchaleelaha, A., Sukbuntherng, J., Chow, H. ‐. S., & Mayersohn, M. (1994) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08390-4 · Cited by 33
Panos, J., & Baker, L. E. (2010) · Psychopharmacology · doi:10.1007/s00213-009-1774-2 · Cited by 17
Cited by
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739
The Toxicology of Bath Salts: A Review of Synthetic Cathinones
Prosser, J. M., & Nelson, L. S. (2012) · Journal of Medical Toxicology · doi:10.1007/s13181-011-0193-z · Cited by 705
Pharmacological characterization of designer cathinones in vitro
Simmler, L., Buser, T., Donzelli, M., Schramm, Y., Dieu, L., Huwyler, J., Chaboz, S., Hoener, M., & Liechti, M. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02145.x · Cited by 672
Baumann, M. H., Ayestas, M. A., Partilla, J. S., Sink, J. R., Shulgin, A. T., Daley, P. F., Brandt, S. D., Rothman, R. B., Ruoho, A. E., & Cozzi, N. V. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.304 · Cited by 439
Baumann, M. H., Partilla, J. S., Lehner, K. R., Thorndike, E. B., Hoffman, A. F., Holy, M., Rothman, R. B., Goldberg, S. R., Lupica, C. R., Sitte, H. H., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.204 · Cited by 408
Metadata
- Authors
- Kehr, J., Ichinose, F., Yoshitake, S., Goiny, M., Sievertsson, T., Nyberg, F., & Yoshitake, T.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2011-11-21
- Volume
- 164
- Issue
- 8
- Pages
- 1949-1958
- ISSN
- 0007-1188 (ISSN-L)
- OpenAlex
- W2165489174
- Cited by
- 312
- References
- 43
- FWCI
- 41.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.